Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 4
1949 1
1950 5
1951 1
1952 1
1953 7
1954 3
1955 9
1956 3
1957 1
1958 8
1959 3
1960 3
1961 2
1962 4
1963 2
1965 2
1966 8
1967 8
1968 7
1969 4
1970 2
1971 8
1972 9
1973 13
1974 11
1975 8
1976 11
1977 7
1978 13
1979 13
1980 11
1981 14
1982 16
1983 15
1984 18
1985 21
1986 23
1987 24
1988 11
1989 18
1990 9
1991 14
1992 12
1993 12
1994 5
1995 6
1996 5
1997 11
1998 10
1999 15
2000 17
2001 6
2002 10
2003 11
2004 10
2005 5
2006 12
2007 10
2008 7
2009 13
2010 15
2011 14
2012 10
2013 17
2014 26
2015 24
2016 19
2017 21
2018 25
2019 31
2020 27
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

757 results
Results by year
Filters applied: . Clear all
Page 1
TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.
Pfeiffer P, Yilmaz M, Möller S, Zitnjak D, Krogh M, Petersen LN, Poulsen LØ, Winther SB, Thomsen KG, Qvortrup C. Pfeiffer P, et al. Among authors: thomsen kg. Lancet Oncol. 2020 Mar;21(3):412-420. doi: 10.1016/S1470-2045(19)30827-7. Epub 2020 Jan 27. Lancet Oncol. 2020. PMID: 31999946 Clinical Trial.
The role of IFN in the development of NAFLD and NASH.
Møhlenberg M, Terczynska-Dyla E, Thomsen KL, George J, Eslam M, Grønbæk H, Hartmann R. Møhlenberg M, et al. Among authors: thomsen kl. Cytokine. 2019 Dec;124:154519. doi: 10.1016/j.cyto.2018.08.013. Epub 2018 Aug 21. Cytokine. 2019. PMID: 30139548 Review.
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK. Suppli MP, et al. Among authors: thomsen kl. Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 30653341 Free article.
Urea cycle dysregulation in non-alcoholic fatty liver disease.
De Chiara F, Heebøll S, Marrone G, Montoliu C, Hamilton-Dutoit S, Ferrandez A, Andreola F, Rombouts K, Grønbæk H, Felipo V, Gracia-Sancho J, Mookerjee RP, Vilstrup H, Jalan R, Thomsen KL. De Chiara F, et al. Among authors: thomsen kl. J Hepatol. 2018 Oct;69(4):905-915. doi: 10.1016/j.jhep.2018.06.023. Epub 2018 Jul 5. J Hepatol. 2018. PMID: 29981428
Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
Kobbernagel HE, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C, Kuehni CE, Lucas JS, Moser CE, Quittner AL, Raidt J, Rosthøj S, Sørensen AL, Thomsen K, Werner C, Omran H, Nielsen KG. Kobbernagel HE, et al. Among authors: thomsen k. Lancet Respir Med. 2020 May;8(5):493-505. doi: 10.1016/S2213-2600(20)30058-8. Lancet Respir Med. 2020. PMID: 32380069 Clinical Trial.
757 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page